DuraTouch® - Post-Market Clinical Follow-up (PMCF) Study in a Real-world Setting
Status: Recruiting
Location: See all (11) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY
This study looks at overall impact of the use of DuraTouch® in terms of ease, convenience to use and satisfaction in participants with either type 1 or type 2 diabetes.The study will last for about 12 weeks.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• The decision to initiate treatment with DuraTouch® has been made by the participant/legally acceptable representative (LAR) and the treating physician before and independently from the decision to include the participant in this study.
• All needed signed consent(s) are obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
Locations
Other Locations
Poland
Poradnia Diabetologiczna. Niepubliczny Zaklad Opieki Zdrowotnej Lege Artis
RECRUITING
Bialystok
Diab Serwis POPENDA Spólka Jawna
RECRUITING
Chorzów
NZOZ Gdanska Poradnia Cukrzycowa Sp. z o.o
RECRUITING
Gdansk
CenterMed Krakow Sp. z o.o.
RECRUITING
Krakow
Santa Familia PTG tódz
RECRUITING
Lodz
Diabetolog praktyka lekarska - Bartosz Bednarkiewicz
RECRUITING
Lubin
Centrum Medyczne Ekamed sp. z o.o.
RECRUITING
Lublin
Diabetica sp. z o.o.
RECRUITING
Nysa
Panstwowy Instytut Medyczny Ministerstwa Spraw Wewnetrznych i Administracji - Klinika Chorob Wewnetrznych, Endokrynologii i Diab
RECRUITING
Warsaw
Ginemedica Sp. z o.o. Sp.k
RECRUITING
Wroclaw
Gabinet Lekarski Internistyczny Iwona Towpik
RECRUITING
Zielona Góra
Contact Information
Primary
Novo Nordisk
clinicaltrials@novonordisk.com
(+1) 866-867-7178
Time Frame
Start Date: 2025-07-01
Estimated Completion Date: 2026-01-02
Participants
Target number of participants: 125
Treatments
DuraTouch® (Insulin injection)
Participants will subcutaneously inject the insulin prescribed by the doctor using DuraTouch® according to routine clinical practice at the discretion of the treating physician.
Related Therapeutic Areas
Sponsors
Leads: Novo Nordisk A/S